Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.78 USD | +3.84% | +10.62% | +31.48% |
Evolution of the average Target Price on Crinetics Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Crinetics Pharmaceuticals, Inc.
HC Wainwright | |
JonesTrading Institutional Services | |
Oppenheimer | |
JMP Securities | |
Citigroup | |
Cantor Fitzgerald | |
Baird | |
Evercore ISI | |
Piper Sandler | |
LifeSci Capital | |
SVB Securities LLC | |
JPMorgan Chase |
EPS Revisions
- Stock Market
- Equities
- CRNX Stock
- Consensus Crinetics Pharmaceuticals, Inc.